nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0915	0.13	CbGbCtD
Etravirine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0915	0.13	CbGbCtD
Etravirine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0761	0.108	CbGbCtD
Etravirine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0761	0.108	CbGbCtD
Etravirine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0584	0.0831	CbGbCtD
Etravirine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0576	0.0821	CbGbCtD
Etravirine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0394	0.0561	CbGbCtD
Etravirine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0384	0.0547	CbGbCtD
Etravirine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0376	0.0536	CbGbCtD
Etravirine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0335	0.0477	CbGbCtD
Etravirine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0328	0.0467	CbGbCtD
Etravirine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.031	0.0441	CbGbCtD
Etravirine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0197	0.028	CbGbCtD
Etravirine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0186	0.0265	CbGbCtD
Etravirine—Rilpivirine—CYP1A2—chronic obstructive pulmonary disease	0.00438	1	CrCbGaD
Etravirine—ABCB4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00319	0.059	CbGpPWpGaD
Etravirine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00244	0.0451	CbGpPWpGaD
Etravirine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00216	0.0399	CbGpPWpGaD
Etravirine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00176	0.0326	CbGpPWpGaD
Etravirine—ABCB4—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.00135	0.025	CbGpPWpGaD
Etravirine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00134	0.0247	CbGpPWpGaD
Etravirine—ABCB4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.00133	0.0245	CbGpPWpGaD
Etravirine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00122	0.0226	CbGpPWpGaD
Etravirine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00122	0.0225	CbGpPWpGaD
Etravirine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00113	0.0209	CbGpPWpGaD
Etravirine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00111	0.0205	CbGpPWpGaD
Etravirine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000973	0.018	CbGpPWpGaD
Etravirine—ABCB4—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000913	0.0169	CbGpPWpGaD
Etravirine—ABCB4—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.000906	0.0167	CbGpPWpGaD
Etravirine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000896	0.0166	CbGpPWpGaD
Etravirine—ABCB4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000887	0.0164	CbGpPWpGaD
Etravirine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000887	0.0164	CbGpPWpGaD
Etravirine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000885	0.0164	CbGpPWpGaD
Etravirine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000807	0.0149	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000738	0.0136	CbGpPWpGaD
Etravirine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000687	0.0127	CbGpPWpGaD
Etravirine—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000643	0.0119	CbGpPWpGaD
Etravirine—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000619	0.0114	CbGpPWpGaD
Etravirine—ABCB4—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000611	0.0113	CbGpPWpGaD
Etravirine—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000586	0.0108	CbGpPWpGaD
Etravirine—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000564	0.0104	CbGpPWpGaD
Etravirine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000541	0.00226	CcSEcCtD
Etravirine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00054	0.00225	CcSEcCtD
Etravirine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000539	0.00225	CcSEcCtD
Etravirine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000539	0.00225	CcSEcCtD
Etravirine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000538	0.00225	CcSEcCtD
Etravirine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000537	0.00224	CcSEcCtD
Etravirine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000534	0.00223	CcSEcCtD
Etravirine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000534	0.00223	CcSEcCtD
Etravirine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000533	0.00223	CcSEcCtD
Etravirine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000532	0.00984	CbGpPWpGaD
Etravirine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000525	0.00219	CcSEcCtD
Etravirine—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.000523	0.00218	CcSEcCtD
Etravirine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000522	0.00218	CcSEcCtD
Etravirine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.00217	CcSEcCtD
Etravirine—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000517	0.00216	CcSEcCtD
Etravirine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000515	0.00215	CcSEcCtD
Etravirine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000515	0.00215	CcSEcCtD
Etravirine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000512	0.00214	CcSEcCtD
Etravirine—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.00214	CcSEcCtD
Etravirine—ABCB4—Metabolism—APIP—chronic obstructive pulmonary disease	0.00051	0.00942	CbGpPWpGaD
Etravirine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00051	0.00213	CcSEcCtD
Etravirine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00051	0.00213	CcSEcCtD
Etravirine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000509	0.00213	CcSEcCtD
Etravirine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000504	0.00211	CcSEcCtD
Etravirine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000504	0.0021	CcSEcCtD
Etravirine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000502	0.0021	CcSEcCtD
Etravirine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000502	0.0021	CcSEcCtD
Etravirine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000502	0.0021	CcSEcCtD
Etravirine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000499	0.00208	CcSEcCtD
Etravirine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000495	0.00207	CcSEcCtD
Etravirine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000495	0.00207	CcSEcCtD
Etravirine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000492	0.00205	CcSEcCtD
Etravirine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000486	0.00203	CcSEcCtD
Etravirine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000482	0.00201	CcSEcCtD
Etravirine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00201	CcSEcCtD
Etravirine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00048	0.002	CcSEcCtD
Etravirine—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000478	0.00883	CbGpPWpGaD
Etravirine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000475	0.00198	CcSEcCtD
Etravirine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000474	0.00198	CcSEcCtD
Etravirine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000474	0.00198	CcSEcCtD
Etravirine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00198	CcSEcCtD
Etravirine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000468	0.00195	CcSEcCtD
Etravirine—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000467	0.00863	CbGpPWpGaD
Etravirine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000466	0.00195	CcSEcCtD
Etravirine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000466	0.00195	CcSEcCtD
Etravirine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000466	0.00195	CcSEcCtD
Etravirine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000466	0.00195	CcSEcCtD
Etravirine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000466	0.00195	CcSEcCtD
Etravirine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000466	0.00195	CcSEcCtD
Etravirine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000465	0.00194	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000464	0.00194	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000464	0.00194	CcSEcCtD
Etravirine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000462	0.00854	CbGpPWpGaD
Etravirine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000462	0.00193	CcSEcCtD
Etravirine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000462	0.00193	CcSEcCtD
Etravirine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000457	0.00191	CcSEcCtD
Etravirine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000457	0.00191	CcSEcCtD
Etravirine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000456	0.00191	CcSEcCtD
Etravirine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000456	0.0019	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000455	0.0019	CcSEcCtD
Etravirine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000454	0.0019	CcSEcCtD
Etravirine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000453	0.00189	CcSEcCtD
Etravirine—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000449	0.0083	CbGpPWpGaD
Etravirine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00187	CcSEcCtD
Etravirine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000445	0.00186	CcSEcCtD
Etravirine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000445	0.00186	CcSEcCtD
Etravirine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00044	0.00184	CcSEcCtD
Etravirine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00044	0.00184	CcSEcCtD
Etravirine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00044	0.00184	CcSEcCtD
Etravirine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000439	0.00183	CcSEcCtD
Etravirine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000436	0.00182	CcSEcCtD
Etravirine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000436	0.00182	CcSEcCtD
Etravirine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000435	0.00182	CcSEcCtD
Etravirine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000435	0.00182	CcSEcCtD
Etravirine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000434	0.00181	CcSEcCtD
Etravirine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000432	0.0018	CcSEcCtD
Etravirine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000431	0.0018	CcSEcCtD
Etravirine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00043	0.0018	CcSEcCtD
Etravirine—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00043	0.0018	CcSEcCtD
Etravirine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000427	0.00178	CcSEcCtD
Etravirine—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000426	0.00787	CbGpPWpGaD
Etravirine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000421	0.00778	CbGpPWpGaD
Etravirine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000421	0.00176	CcSEcCtD
Etravirine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000419	0.00175	CcSEcCtD
Etravirine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000416	0.00174	CcSEcCtD
Etravirine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000415	0.00173	CcSEcCtD
Etravirine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000413	0.00172	CcSEcCtD
Etravirine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00172	CcSEcCtD
Etravirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000411	0.00759	CbGpPWpGaD
Etravirine—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00041	0.00757	CbGpPWpGaD
Etravirine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000409	0.00171	CcSEcCtD
Etravirine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.00171	CcSEcCtD
Etravirine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000405	0.00169	CcSEcCtD
Etravirine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.00169	CcSEcCtD
Etravirine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00169	CcSEcCtD
Etravirine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000403	0.00168	CcSEcCtD
Etravirine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000403	0.00745	CbGpPWpGaD
Etravirine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000399	0.00167	CcSEcCtD
Etravirine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.00167	CcSEcCtD
Etravirine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000397	0.00166	CcSEcCtD
Etravirine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000394	0.00165	CcSEcCtD
Etravirine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00039	0.00163	CcSEcCtD
Etravirine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00039	0.00163	CcSEcCtD
Etravirine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000387	0.00162	CcSEcCtD
Etravirine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000387	0.00162	CcSEcCtD
Etravirine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000387	0.00715	CbGpPWpGaD
Etravirine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000387	0.00161	CcSEcCtD
Etravirine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000387	0.00161	CcSEcCtD
Etravirine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000384	0.00709	CbGpPWpGaD
Etravirine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000383	0.0016	CcSEcCtD
Etravirine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.0016	CcSEcCtD
Etravirine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000383	0.0016	CcSEcCtD
Etravirine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.0016	CcSEcCtD
Etravirine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.0016	CcSEcCtD
Etravirine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000382	0.0016	CcSEcCtD
Etravirine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00159	CcSEcCtD
Etravirine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000379	0.00158	CcSEcCtD
Etravirine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000379	0.00158	CcSEcCtD
Etravirine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00157	CcSEcCtD
Etravirine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000376	0.00157	CcSEcCtD
Etravirine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000375	0.00157	CcSEcCtD
Etravirine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000375	0.00156	CcSEcCtD
Etravirine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000373	0.00156	CcSEcCtD
Etravirine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000373	0.00156	CcSEcCtD
Etravirine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000372	0.00687	CbGpPWpGaD
Etravirine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000371	0.00155	CcSEcCtD
Etravirine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000371	0.00155	CcSEcCtD
Etravirine—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00037	0.00685	CbGpPWpGaD
Etravirine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.00155	CcSEcCtD
Etravirine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000369	0.00154	CcSEcCtD
Etravirine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000369	0.00154	CcSEcCtD
Etravirine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000369	0.00154	CcSEcCtD
Etravirine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.00154	CcSEcCtD
Etravirine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000367	0.00153	CcSEcCtD
Etravirine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000367	0.00153	CcSEcCtD
Etravirine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000367	0.00153	CcSEcCtD
Etravirine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00153	CcSEcCtD
Etravirine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.00152	CcSEcCtD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000364	0.00672	CbGpPWpGaD
Etravirine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00151	CcSEcCtD
Etravirine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.00151	CcSEcCtD
Etravirine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000359	0.0015	CcSEcCtD
Etravirine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000354	0.00148	CcSEcCtD
Etravirine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000354	0.00148	CcSEcCtD
Etravirine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000354	0.00148	CcSEcCtD
Etravirine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000354	0.00148	CcSEcCtD
Etravirine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000353	0.00148	CcSEcCtD
Etravirine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00035	0.00146	CcSEcCtD
Etravirine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00035	0.00146	CcSEcCtD
Etravirine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00035	0.00146	CcSEcCtD
Etravirine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00146	CcSEcCtD
Etravirine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000348	0.00145	CcSEcCtD
Etravirine—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000347	0.00641	CbGpPWpGaD
Etravirine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000347	0.00145	CcSEcCtD
Etravirine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000347	0.00145	CcSEcCtD
Etravirine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00145	CcSEcCtD
Etravirine—ABCB4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000338	0.00624	CbGpPWpGaD
Etravirine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000336	0.00621	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000335	0.00619	CbGpPWpGaD
Etravirine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.0014	CcSEcCtD
Etravirine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.0014	CcSEcCtD
Etravirine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00138	CcSEcCtD
Etravirine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00138	CcSEcCtD
Etravirine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00033	0.00138	CcSEcCtD
Etravirine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000329	0.00137	CcSEcCtD
Etravirine—ABCB4—Metabolism—GC—chronic obstructive pulmonary disease	0.000329	0.00607	CbGpPWpGaD
Etravirine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000324	0.00135	CcSEcCtD
Etravirine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000323	0.00596	CbGpPWpGaD
Etravirine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000322	0.00134	CcSEcCtD
Etravirine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.00134	CcSEcCtD
Etravirine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000315	0.00132	CcSEcCtD
Etravirine—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000312	0.0013	CcSEcCtD
Etravirine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000312	0.0013	CcSEcCtD
Etravirine—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000309	0.00571	CbGpPWpGaD
Etravirine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00128	CcSEcCtD
Etravirine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00128	CcSEcCtD
Etravirine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000306	0.00565	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000306	0.00564	CbGpPWpGaD
Etravirine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000304	0.00127	CcSEcCtD
Etravirine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.00127	CcSEcCtD
Etravirine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00126	CcSEcCtD
Etravirine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00124	CcSEcCtD
Etravirine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00124	CcSEcCtD
Etravirine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00121	CcSEcCtD
Etravirine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.00121	CcSEcCtD
Etravirine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00119	CcSEcCtD
Etravirine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00119	CcSEcCtD
Etravirine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00118	CcSEcCtD
Etravirine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00118	CcSEcCtD
Etravirine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00118	CcSEcCtD
Etravirine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00118	CcSEcCtD
Etravirine—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000282	0.00521	CbGpPWpGaD
Etravirine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000281	0.00519	CbGpPWpGaD
Etravirine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00117	CcSEcCtD
Etravirine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00117	CcSEcCtD
Etravirine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.00117	CcSEcCtD
Etravirine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00117	CcSEcCtD
Etravirine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00028	0.00117	CcSEcCtD
Etravirine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000279	0.00117	CcSEcCtD
Etravirine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00116	CcSEcCtD
Etravirine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00116	CcSEcCtD
Etravirine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000276	0.00115	CcSEcCtD
Etravirine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00115	CcSEcCtD
Etravirine—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000273	0.00505	CbGpPWpGaD
Etravirine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000273	0.00114	CcSEcCtD
Etravirine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000272	0.00114	CcSEcCtD
Etravirine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00113	CcSEcCtD
Etravirine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00113	CcSEcCtD
Etravirine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00027	0.00499	CbGpPWpGaD
Etravirine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00112	CcSEcCtD
Etravirine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000268	0.00112	CcSEcCtD
Etravirine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000267	0.00112	CcSEcCtD
Etravirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000267	0.00493	CbGpPWpGaD
Etravirine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00112	CcSEcCtD
Etravirine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000267	0.00111	CcSEcCtD
Etravirine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00111	CcSEcCtD
Etravirine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000266	0.00111	CcSEcCtD
Etravirine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000266	0.00111	CcSEcCtD
Etravirine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00111	CcSEcCtD
Etravirine—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000264	0.00487	CbGpPWpGaD
Etravirine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.00109	CcSEcCtD
Etravirine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000261	0.00109	CcSEcCtD
Etravirine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000258	0.00108	CcSEcCtD
Etravirine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000257	0.00107	CcSEcCtD
Etravirine—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000256	0.00474	CbGpPWpGaD
Etravirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000253	0.00467	CbGpPWpGaD
Etravirine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.00105	CcSEcCtD
Etravirine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00025	0.00105	CcSEcCtD
Etravirine—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000249	0.0046	CbGpPWpGaD
Etravirine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000244	0.00102	CcSEcCtD
Etravirine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000244	0.0045	CbGpPWpGaD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000243	0.0045	CbGpPWpGaD
Etravirine—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00024	0.00444	CbGpPWpGaD
Etravirine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.000998	CcSEcCtD
Etravirine—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000236	0.00436	CbGpPWpGaD
Etravirine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.000981	CcSEcCtD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000234	0.00432	CbGpPWpGaD
Etravirine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00097	CcSEcCtD
Etravirine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000941	CcSEcCtD
Etravirine—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000225	0.00415	CbGpPWpGaD
Etravirine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000937	CcSEcCtD
Etravirine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.000917	CcSEcCtD
Etravirine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.000911	CcSEcCtD
Etravirine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000909	CcSEcCtD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.004	CbGpPWpGaD
Etravirine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000903	CcSEcCtD
Etravirine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.000867	CcSEcCtD
Etravirine—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000205	0.00378	CbGpPWpGaD
Etravirine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000851	CcSEcCtD
Etravirine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000838	CcSEcCtD
Etravirine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.000836	CcSEcCtD
Etravirine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000835	CcSEcCtD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000199	0.00367	CbGpPWpGaD
Etravirine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000199	0.00367	CbGpPWpGaD
Etravirine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000825	CcSEcCtD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000197	0.00365	CbGpPWpGaD
Etravirine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000814	CcSEcCtD
Etravirine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000811	CcSEcCtD
Etravirine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000194	0.00359	CbGpPWpGaD
Etravirine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00081	CcSEcCtD
Etravirine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000192	0.00354	CbGpPWpGaD
Etravirine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000794	CcSEcCtD
Etravirine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000783	CcSEcCtD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000187	0.00346	CbGpPWpGaD
Etravirine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000187	0.00078	CcSEcCtD
Etravirine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000766	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000764	CcSEcCtD
Etravirine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000182	0.00076	CcSEcCtD
Etravirine—ABCB4—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.00018	0.00332	CbGpPWpGaD
Etravirine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.000747	CcSEcCtD
Etravirine—ABCB4—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000177	0.00328	CbGpPWpGaD
Etravirine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000177	0.00327	CbGpPWpGaD
Etravirine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000732	CcSEcCtD
Etravirine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000175	0.00323	CbGpPWpGaD
Etravirine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000725	CcSEcCtD
Etravirine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000723	CcSEcCtD
Etravirine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000172	0.00318	CbGpPWpGaD
Etravirine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000716	CcSEcCtD
Etravirine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000713	CcSEcCtD
Etravirine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000703	CcSEcCtD
Etravirine—ABCB4—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000165	0.00306	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000164	0.00304	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000162	0.00299	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.00297	CbGpPWpGaD
Etravirine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000671	CcSEcCtD
Etravirine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.00016	0.00296	CbGpPWpGaD
Etravirine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000667	CcSEcCtD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000159	0.00293	CbGpPWpGaD
Etravirine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000662	CcSEcCtD
Etravirine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.00291	CbGpPWpGaD
Etravirine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000641	CcSEcCtD
Etravirine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000153	0.00283	CbGpPWpGaD
Etravirine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.00064	CcSEcCtD
Etravirine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000639	CcSEcCtD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000152	0.00281	CbGpPWpGaD
Etravirine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000635	CcSEcCtD
Etravirine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.000635	CcSEcCtD
Etravirine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000151	0.00063	CcSEcCtD
Etravirine—ABCB4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000149	0.00276	CbGpPWpGaD
Etravirine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000607	CcSEcCtD
Etravirine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.00267	CbGpPWpGaD
Etravirine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000603	CcSEcCtD
Etravirine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000603	CcSEcCtD
Etravirine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000143	0.00265	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000142	0.00262	CbGpPWpGaD
Etravirine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000583	CcSEcCtD
Etravirine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000583	CcSEcCtD
Etravirine—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000138	0.00256	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000137	0.00253	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00013	0.00241	CbGpPWpGaD
Etravirine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00013	0.000543	CcSEcCtD
Etravirine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000529	CcSEcCtD
Etravirine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000126	0.00233	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000125	0.0023	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000124	0.0023	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000123	0.00227	CbGpPWpGaD
Etravirine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000504	CcSEcCtD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.00012	0.00221	CbGpPWpGaD
Etravirine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.00216	CbGpPWpGaD
Etravirine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000487	CcSEcCtD
Etravirine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000115	0.00213	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.00213	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000114	0.00211	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.0021	CbGpPWpGaD
Etravirine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000469	CcSEcCtD
Etravirine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000465	CcSEcCtD
Etravirine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000464	CcSEcCtD
Etravirine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000462	CcSEcCtD
Etravirine—ABCB4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.002	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.00194	CbGpPWpGaD
Etravirine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000438	CcSEcCtD
Etravirine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.00191	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.73e-05	0.0018	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.59e-05	0.00177	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.46e-05	0.00175	CbGpPWpGaD
Etravirine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.46e-05	0.00175	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.87e-05	0.00164	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.82e-05	0.00163	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	8.77e-05	0.00162	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.75e-05	0.00162	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.69e-05	0.00161	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.63e-05	0.00159	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	8.41e-05	0.00155	CbGpPWpGaD
Etravirine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.36e-05	0.00154	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.32e-05	0.00154	CbGpPWpGaD
Etravirine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.24e-05	0.00152	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.23e-05	0.00152	CbGpPWpGaD
Etravirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	8.22e-05	0.00152	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.04e-05	0.00149	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.93e-05	0.00146	CbGpPWpGaD
Etravirine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.62e-05	0.00141	CbGpPWpGaD
Etravirine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.52e-05	0.00139	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—ALB—chronic obstructive pulmonary disease	7.37e-05	0.00136	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	7.12e-05	0.00132	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.05e-05	0.0013	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.92e-05	0.00128	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.82e-05	0.00126	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	6.72e-05	0.00124	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	6.56e-05	0.00121	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	6.54e-05	0.00121	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	6.13e-05	0.00113	CbGpPWpGaD
Etravirine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	6.1e-05	0.00113	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.77e-05	0.00107	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.69e-05	0.00105	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.3e-05	0.000979	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.23e-05	0.000966	CbGpPWpGaD
Etravirine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.03e-05	0.000929	CbGpPWpGaD
Etravirine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.96e-05	0.000916	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.79e-05	0.000886	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.45e-05	0.000823	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.42e-05	0.000816	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.37e-05	0.000808	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.35e-05	0.000803	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	4.33e-05	0.0008	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	4.23e-05	0.000781	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.06e-05	0.00075	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.04e-05	0.000747	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.03e-05	0.000744	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.03e-05	0.000744	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.95e-05	0.00073	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.93e-05	0.000726	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.67e-05	0.000679	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.51e-05	0.000649	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.37e-05	0.000623	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.22e-05	0.000596	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.21e-05	0.000593	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.16e-05	0.000584	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.01e-05	0.000556	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.93e-05	0.000541	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.68e-05	0.000495	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.65e-05	0.000491	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.61e-05	0.000481	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.42e-05	0.000447	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.37e-05	0.000437	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	2.34e-05	0.000432	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.31e-05	0.000427	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.28e-05	0.000422	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.18e-05	0.000403	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.16e-05	0.000399	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	2.13e-05	0.000394	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.13e-05	0.000394	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.08e-05	0.000385	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.02e-05	0.000374	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.99e-05	0.000367	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.97e-05	0.000363	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.95e-05	0.00036	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.92e-05	0.000355	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.79e-05	0.000331	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.64e-05	0.000303	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.62e-05	0.000299	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.6e-05	0.000296	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.58e-05	0.000292	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.51e-05	0.000279	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.5e-05	0.000276	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.48e-05	0.000273	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.47e-05	0.000272	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.000264	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.42e-05	0.000263	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.41e-05	0.00026	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.39e-05	0.000258	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.37e-05	0.000254	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.3e-05	0.000241	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.28e-05	0.000237	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.18e-05	0.000219	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.87e-06	0.000182	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.73e-06	0.00018	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	9.71e-06	0.000179	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	9.48e-06	0.000175	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	9.29e-06	0.000172	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.07e-06	0.000168	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.07e-06	0.000167	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	8.86e-06	0.000164	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.59e-06	0.000159	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	8.47e-06	0.000157	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.84e-06	0.000108	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.59e-06	0.000103	CbGpPWpGaD
